Dr Jenn King joins Exopharm Board

Exopharm Limited (ASX: EX1) is pleased to announce the appointment of Dr Jennifer (Jenn) King to the Exopharm Board, effective 1 September 2021.
Dr King joins the Company’s Board as an independent Non-executive Director, and will continue in her role as a member of the Company’s Advisory Panel under her existing terms of appointment to the Panel.

ASX RELEASE 31.08.2021

GET INVESTMENT OPPORTUNITIES OR
RAISE CAPITAL

Contact Us